CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 110 enrolled
Drug / intervention
The reliability and validity study of the T-LUNSother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT06278805
NCT06278805N/ACompleted

Adaptation and Validation Study of the Longer- Term Unmet Needs After Stroke Questionnaire Into Turkish

Uşak University·observational·Posted Feb 26, 2024·Updated Jul 9, 2025

In Brief

An observational study evaluating The reliability and validity study of the T-LUNS for Stroke and 2 related conditions. Completed, enrolled 110 participants across 1 site.

Detailed Summary

According to the most up-to-date knowledge, there is no Turkish comprehensive and validated instrument to assess stroke survivors' unmet needs in the longer term. So, this study aims to translate and adapt the LUNS into Turkish and examine its psychometric properties in survivors living at home after a stroke. Our hypothesis in this study is: \- The Turkish Longer-term Unmet Needs after Stroke Questionnaire (T-LUNS) is a valid tool for assessing the unmet needs of stroke patients in the Turkish population.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesTurkey (Türkiye)

Timeline

N/ACompletedFinished
20252026
First PostedFeb 26, 2024
Enrollment StartMar 1, 2024
Primary CompletionJul 1, 2025
Study CompletionJul 4, 2025
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 2.4 years ago

Interventions

The reliability and validity study of the T-LUNSother

To test the reliability and validity of the T-LUNS, 110 chronic stroke survivors fulfilling the inclusion / exclusion criteria at the 3 study sites will be assessed. The assessment of each patient will include recording of the demographic and clinical characteristics and administration of the T-LUNS as well as the Turkish version of the Stroke Impact Scale 3.0 (SIS). For the assessment of test-retest reliability of the T-LUNS, half of the participants (n= 55) will fill in the T-LUNS again, 2 weeks after the first administration.